- Home
- EML vs RVNC Comparison
EML vs RVNC Comparison
Compare EML & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- RVNC
- Stock Information
- Founded
- EML 1858
- RVNC 1999
- Country
- EML United States
- RVNC United States
- Employees
- EML N/A
- RVNC N/A
- Industry
- EML Industrial Machinery/Components
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- RVNC Health Care
- Exchange
- EML Nasdaq
- RVNC Nasdaq
- Market Cap
- EML N/A
- RVNC 546.4M
- IPO Year
- EML N/A
- RVNC 2014
- Fundamental
- Price
- EML $32.74
- RVNC $5.28
- Analyst Decision
- EML
- RVNC Buy
- Analyst Count
- EML 0
- RVNC 10
- Target Price
- EML N/A
- RVNC $10.86
- AVG Volume (30 Days)
- EML 33.5K
- RVNC 3.6M
- Earning Date
- EML 11-05-2024
- RVNC 11-06-2024
- Dividend Yield
- EML 1.34%
- RVNC N/A
- EPS Growth
- EML 65.47
- RVNC N/A
- EPS
- EML 1.92
- RVNC N/A
- Revenue
- EML $273,702,675.00
- RVNC $251,178,000.00
- Revenue This Year
- EML N/A
- RVNC $20.36
- Revenue Next Year
- EML N/A
- RVNC $31.66
- P/E Ratio
- EML $17.06
- RVNC N/A
- Revenue Growth
- EML N/A
- RVNC 40.23
- 52 Week Low
- EML $16.10
- RVNC $2.30
- 52 Week High
- EML $35.78
- RVNC $9.90
- Technical
- Relative Strength Index (RSI)
- EML 60.27
- RVNC 39.70
- Support Level
- EML $31.49
- RVNC $5.13
- Resistance Level
- EML $33.00
- RVNC $5.41
- Average True Range (ATR)
- EML 1.07
- RVNC 0.20
- MACD
- EML -0.06
- RVNC -0.02
- Stochastic Oscillator
- EML 72.94
- RVNC 42.19
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.